Senate Bill 16 for the first time permits reciprocity for qualifying patients from other states and expands the pool of patients eligible to possess CBD to include those with autism, epidermolysis bullosa, AIDS, Tourette’s Syndrome, severe peripheral neuropathy, or who are in hospice care.

Over 1,700 Georgians are registered to possess CBD-derived products. However, the law neither provides for an in-state supply source for CBD, nor does it establish a regulated distribution system for CBD-specific products.

Sixteen states have enacted similar laws explicitly recognizing cannabidiol as a therapeutic agent.

For more information, please contact Justin Strekal, NORML Political Director, at (202) 483-5500.